Ingersoll Rand India Target Raised to Rs 5,029 by Brokerage

INDUSTRIAL-GOODSSERVICES
Whalesbook Logo
AuthorRiya Kapoor|Published at:
Ingersoll Rand India Target Raised to Rs 5,029 by Brokerage

Prabhudas Lilladher has raised the price target for Ingersoll Rand (India) to Rs 5,029. As of August 14, 2026, the stock trades near Rs 4,735. The company's focus on local manufacturing at its Sanand facility and its debt-free balance sheet support the positive outlook, though investors are watching for risks related to high valuations and cyclical demand.

Shares of Ingersoll Rand (India) are in focus today after brokerage firm Prabhudas Lilladher maintained an ‘Accumulate’ rating and revised its price target upward to Rs 5,029. As of August 14, 2026, the stock is trading at approximately Rs 4,735.

The positive view on the company is primarily driven by its operational strategy and expansion efforts. A central part of this plan is the Sanand facility in Gujarat, which is designed to reduce production bottlenecks and increase output. The company has made significant progress in localization, with over 90% of its rotary screw compressors now manufactured domestically. This shift helps the company manage costs and reduce dependency on imports, which is expected to support profit margins in the medium term.

From a financial perspective, the company ended the financial year 2026 with total revenue of Rs 1,392 crore and a net profit of Rs 256 crore. A notable strength of the company is its clean balance sheet; it remains effectively debt-free. This financial position offers the company flexibility to navigate market volatility without the pressure of interest repayments.

However, the current market valuation remains an important consideration for investors. The stock trades at a premium to its book value and carries a higher valuation than the industry median. Because Ingersoll Rand operates in the industrial goods sector, its business is inherently linked to economic cycles. When industries like automotive, infrastructure, or pharmaceuticals face a slowdown, the demand for compressors can also moderate.

Investors should also monitor potential risks that could impact future growth. Raw material price fluctuations can put pressure on operating margins if not managed through pricing or efficiency gains. Additionally, while the company has a strong footprint, it faces geopolitical risks that could affect its export volumes to parent group companies. Another factor to watch is the decision-making cycle of customers; if industrial projects are delayed, it can lead to longer timelines for revenue realization.

Looking ahead, the company’s ability to execute its expansion plans and maintain its market share in the high-capacity compressor segment will be key monitorables. The market will likely watch for further updates on order flow and how the company manages cost pressures in the coming quarters.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.